Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
Authors
Keywords
-
Journal
Science Signaling
Volume 11, Issue 551, Pages eaat9773
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-10-10
DOI
10.1126/scisignal.aat9773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HER kinase inhibition in patients with HER2- and HER3-mutant cancers
- (2018) David M. Hyman et al. NATURE
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
- (2016) W.-J. Zuo et al. CLINICAL CANCER RESEARCH
- HER2missense mutations have distinct effects on oncogenic signaling and migration
- (2015) Daniel J. Zabransky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer
- (2014) Delphine R. Boulbes et al. Molecular Oncology
- Human Breast Cancer Cells Harboring a Gatekeeper T798M Mutation in HER2 Overexpress EGFR Ligands and Are Sensitive to Dual Inhibition of EGFR and HER2
- (2013) B. N. Rexer et al. CLINICAL CANCER RESEARCH
- Biomarkers of drugs targeting HER-family signalling in cancer
- (2013) Filippo Montemurro et al. JOURNAL OF PATHOLOGY
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Clinical Response to a Lapatinib-Based Therapy for a Li-Fraumeni Syndrome Patient with a Novel HER2V659E Mutation
- (2013) V. Serra et al. Cancer Discovery
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
- (2012) Ron Bose et al. Cancer Discovery
- A framework for variation discovery and genotyping using next-generation DNA sequencing data
- (2011) Mark A DePristo et al. NATURE GENETICS
- High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
- (2011) Nikhil Wagle et al. Cancer Discovery
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation
- (2008) T. Trowe et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation